(Q53615781)

16 May 2018

title

Plasma exchange in severe hypertriglyceridemia a clinical study. (English)

1 reference

16 May 2018

1 reference

Gurhan Kadikoylu

1

1 reference

16 May 2018

Irfan Yavasoglu

series ordinal

2

1 reference

16 May 2018

Zahit Bolaman

series ordinal

3

1 reference

16 May 2018

publication date

22 June 2006

1 reference

16 May 2018

Transfusion and Apheresis Science

published in

1 reference

16 May 2018

volume

34

1 reference

16 May 2018

issue

3

1 reference

16 May 2018

page(s)

253-257

1 reference

16 May 2018

Triglyceride concentration and ischemic heart disease: an eight-year follow-up in the Copenhagen Male Study.

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Epidemiology of triglycerides: a view from Framingham

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Issues in hyperlipidemic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Cholesterol lowering with statin drugs, risk of stroke, and total mortality. An overview of randomized trials

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Plasmapheresis for severe lipemia: Comparison of serum‐lipid clearance rates for the plasma‐exchange and double‐filtration variants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Prevention of recurrent acute pancreatitis in patients with severe hypertriglyceridemia: value of regular plasmapheresis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Pregnancy outcome in familial homozygous hypercholesterolemic females treated with long-term plasma exchange

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Does correction of the friedewald formula using lipoprotein(a) change our estimation of ischemic heart disease risk? The Quebec Cardiovascular Study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Plasmapheresis for hyperlipidemic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Long-term follow-up of patients with acute hypertriglyceridemia-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Evaluation of double filtration plasmapheresis, thermofiltration, and low-density lipoprotein adsorptive methods by crossover test in the treatment of familial hypercholesterolemia patients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Plasmapheresis by using secondary membrane filters: twelve years of experience

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Plasma exchange for hypertriglyceridemic acute necrotizing pancreatitis: report of two cases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Plasmapheresis as an adjuvant therapy for hypertriglyceridemia-induced pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Selective removal of triglyceride-rich lipoproteins by plasmapheresis in diabetic patients with severe hypertriglyceridemia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Cyclosporin-induced hypertriglyceridemia with prompt response to plasma exchange therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Intensive, long-term plasma exchange therapy for severe hypertriglyceridemia in acquired generalized lipoatrophy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Therapeutic apheresis in renal and metabolic diseases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Effect of different LDL-apheresis methods on parameters involved in atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Intraindividual comparison of two extracorporeal LDL apheresis methods: lipidfiltration and HELP.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

LDL-apheresis: results of longterm treatment and vascular outcome

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

The HELP-LDL-apheresis multicentre study, an angiographically assessed trial on the role of LDL-apheresis in the secondary prevention of coronary heart disease. II. Final evaluation of the effect of regular treatment on LDL-cholesterol plasma concen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

Therapeutic plasma exchange in patients with hyperlipidemic pancreatitis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSCI.2005.11.009

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1016/J.TRANSCI.2005.11.009

1 reference

16 May 2018

PubMed ID

16798091

1 reference

16 May 2018